Literature DB >> 581674

Suppression of antibody-sensitized tumor cells by macrophages: insufficient supply or activation of macrophages within large tumors.

R J Johnson, R F Siliciano, H S Shin.   

Abstract

Systemic administration of antibody against the C3H lymphosarcoma 6C3HED caused complete suppression of the growth of 10(5) tumor cells. When the size of the tumor inoculum was increased to 10(6) tumor cells, excess antibody was unable to cause complete suppression unless exogenous macrophages were added to the tumor inocula. The decreased effectiveness of antibody was shown to be caused by a local deficiency in the supply or activation of macrophages within the large tumor grafts and not by a systemic deficiency.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 581674

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  Macrophages and antitumor reactions.

Authors:  W Den Otter; H F Dullens; R A De Weger
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

2.  Effects of isolated tumor lymphocytes alone and with adherent cells.

Authors:  B A Blazar; N Galili; E Klein
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

3.  Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis.

Authors:  D O Adams; T Hall; Z Steplewski; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

4.  Complete suppression of in vivo growth of human leukemia cells by specific immunotoxins: nude mouse models.

Authors:  H Hara; B K Seon
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen.

Authors:  C C Badger; I D Bernstein
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.